The busiest week of earnings has passed, but there are still dozens of key reports still to come that could shake up Wall Street. About 120 S & P 500 companies are scheduled to post their latest earnings. Among them are Disney , Advanced Micro Devices and Dow Jones Industrial Average member Pfizer . Those come after investors last week got quarterly reports from megacap names including Microsoft , Apple , Amazon and Meta Platforms . Roughly two-thirds of the companies in the S & P 500 index have posted quarterly results, with more than 82% exceeding earnings expectations, according to FactSet. Take a look at CNBC Pro’s breakdown of what to expect in this week’s key reports. All times are ET. Tuesday Pfizer is set to report earnings before the bell. A call is scheduled for 10 a.m. Last quarter: PFE topped expectations as it expanded cost-cutting efforts . This quarter: Analysts expect the pharmaceutical giant to report a slight year-over-year earnings decline, according to LSEG. What to watch: Investors will look for guidance around President Donald Trump’s push to lower drug prices — and how that could affect Pfizer’s future earnings. The earnings call will likely focus on “RFK Jr and possible risks to vaccines; [and] obesity franchise aspirations and/or other early pipeline opportunities like PFE’s next-gen PCV vaccines,” BofA analyst Tim Anderson said last month, referring to the Secretary of Health and Human Services. What history shows: Pfizer has a strong track record of exceeding earnings estimates, with the company’s bottom line beating expectations 87% of the time, according to Bespoke Investment Group. AMD is set to report earnings after the close, followed by a conference call at 5 p.m. Last quarter: AMD beat on earnings but said it would take a $1.5 billion revenue hit due to restrictions on sales of chips to China. This quarter: Analysts polled by LSEG expect a mixed quarter, with earnings forecast to have dropped nearly 30% year over year, while revenue is anticipated to have grown more than 25%. What to watch: “We see an upside bias for FQ2 (June) results driven by both PC and server” demand, wrote UBS analyst Tim Arcuri on July 28, who rates AMD a buy. “Investors should, however, not expect any quantitative data center GPU commentary for next year as it is probably still too early for AMD to talk about next year other than to say that it feels very good about growth,” he added, referring to graphics processing units. What history shows: AMD has fallen after two of the last three earnings releases, including a 6.3% slide after Q4 results came out and an 11% slump following mixed Q3 figures. Super Micro Computer is set to report earnings postmarket. Management’s conference call with analysts and institutional investors is slated for 5 p.m. Last quarter: SMCI issued weak guidance, citing ” economic uncertainty and tariff impacts .” This quarter: The data center company is expected to post a steep, year-over-year decline in earnings, LSEG data shows. What to watch: JPMorgan analyst Samik Chatterjee placed SMCI on “negative catalyst watch” ahead of these forthcoming earnings, noting “upside in relation to AI demand drivers is likely to be offset by margin pressures stemming from an increasingly competitive landscape, driving downside to the premium valuation multiple SMCI shares are currently trading at.” What history shows: According to Bespoke, Super Micro only beats earnings estimates 64% of the time. However, the stock averages a 2.3% advance when the company reports its latest financials. Wednesday Disney is set to report earnings before the bell, followed by a call at 8:30 a.m. Last quarter: DIS climbed on a surprise uptick in streaming subscribers . This quarter: Analysts anticipate the theme park and media giant will report year-over-year earnings growth of about 7%, per LSEG. What to watch: Disney shares have struggled recently, losing more than 5% in the past month, while the S & P 500 is up slightly. Can this report put the House of Mouse back on track? What history shows: Disney earnings have topped earnings expectations in seven of the last eight quarters, per Bespoke. Thursday Eli Lilly is set to report earnings premarket, with a call slated for 8:30 a.m. Last quarter: LLY posted a 45% sales surge on strong demand for weight loss drugs. This quarter: Analysts polled by LSEG expect the Indianapolis-based drugmaker to reveal earnings growth of around 40%. What to watch: Investors will look for continued momentum out of Eli Lilly’s Mounjaro weight loss drug. Last week, Lilly said Mounjaro has shown similar heart health benefits in a head-to-head trial with diabetes drug Trulicity, also made by Lilly. What history shows: Bespoke data shows Lilly beats Wall Street expectations 66% of the time. However, the stock doesn’t perform well on earnings days, averaging a 0.2% decline.